Policy and training to reduce sales to intoxicated customers in Oregon’s legal marijuana market
Official title: Policy and Training Intervention in Responsible Marijuana Sales Practices to Reduce the Risk of Selling to Intoxicated Customers
Funded at Klein Buendel, INC. · NIH-11406244 · Data updated 2026-11-12
A program to test how policy changes and staff training can help prevent selling marijuana to clearly intoxicated customers in Oregon.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Klein Buendel, INC. NIH-funded |
| Lab location | 1 site (Lakewood, UNITED STATES) |
| Project start | September 20, 2023 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $653,389 |
| NIH project number | 5R01AA031591-04 |
| Project ID | NIH-11406244 on NIH RePORTER |
Who could benefit from this research
✓Could help
Not applicable to individual patients; results aim to inform store policies and public health protections for the general community.
✕Less likely to help
No direct treatment or medical intervention for patients is involved.
What this research studies
This project tests a policy-and-training approach in state-licensed Oregon marijuana stores to deter sales to visibly intoxicated patrons. It uses online training and store-management practices to recognize intoxication and refuse purchases, with assessments conducted in about 213 stores around Portland. The study follows real-world store operations and measures outcomes related to policy compliance and sale refusals. The goal is to find practical, scalable ways to reduce impaired-driving and related harms from marijuana use combined with alcohol.
Why it matters
Potential benefit: If successful, it could provide a validated, easy-to-implement method for retailers to reduce impaired driving and injuries.
How similar studies have gone: Previous work suggests training and policy changes can influence retailer behavior and reduce risky sales; this study builds on those concepts in a state-regulated market.
Where this research is happening
-
Klein Buendel, INC.
Lakewood, United States Active
Researchers
- Principal investigator: Woodall, W Gill — Klein Buendel, INC.
- Study coordinator: Woodall, W Gill
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.